{"data":[{"accessionNo":"0001649553-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":"03835L702","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"CVI Investments, Inc.","reportingCik":null,"personType":"CO","sharesOwned":83854,"percentOfClass":6.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0001649553-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":"03835L702","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Heights Capital Management, Inc.","reportingCik":null,"personType":"CO","sharesOwned":83854,"percentOfClass":6.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0001666270-26-000004","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":"03835L702","securityClass":"Common Stock","eventDate":"2026-05-25","reportingPerson":"NIOWAVE, INC.","reportingCik":null,"personType":"CO","sharesOwned":151723,"percentOfClass":12.2,"filedAt":"2026-06-22","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0001649553-26-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"CVI Investments, Inc.","reportingCik":null,"personType":"CO","sharesOwned":83854,"percentOfClass":8.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0001649553-26-000020","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Heights Capital Management, Inc.","reportingCik":null,"personType":"CO","sharesOwned":83854,"percentOfClass":8.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000902664-26-001127","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000902664-26-001127","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000902664-26-001127","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000070858-25-000408","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-31","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":86,"percentOfClass":0,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000070858-25-000377","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":494341,"percentOfClass":15,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000902664-25-004113","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-16","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":299944,"percentOfClass":9.1,"filedAt":"2025-09-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000902664-25-004113","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-16","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":299944,"percentOfClass":9.1,"filedAt":"2025-09-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"},{"accessionNo":"0000902664-25-004113","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001671584","issuerName":"Aptevo Therapeutics Inc.","ticker":"APVO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-16","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":299944,"percentOfClass":9.1,"filedAt":"2025-09-17","canonicalUrl":"https://xoomar.com/markets/stocks/apvo"}],"updatedAt":"2026-11-04T05:18:50.227Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/apvo","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}